File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/0006-8993(92)90869-B
- Scopus: eid_2-s2.0-0027049414
- PMID: 1283561
- WOS: WOS:A1992KF96900026
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Decrease of enkephalins in cerebellum during Wobbler mouse motoneuron disease
Title | Decrease of enkephalins in cerebellum during Wobbler mouse motoneuron disease |
---|---|
Authors | |
Keywords | Cerebellum Corpus striatum Leucine enkephalin Methionine enkephalin Motoneuron disease Radioimmunoassay Substance P Thyrotropin-releasing hormone Wobbler mouse |
Issue Date | 1992 |
Publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/brainres |
Citation | Brain Research, 1992, v. 599 n. 1, p. 175-180 How to Cite? |
Abstract | The Wobbler mouse possesses an inherited motoneuron disease, which expresses itself primarily at cervical spinal levels and in cranial motor nuclei. Cell degeneration is sporatic and negligible in other motor regions of the brain (e.g., cerebellum, corpus striatum). However, enkephalin concentrations are consistently lower in the Wobbler cerebellum throughout the motoneuron disease, whereas substance P concentrations are significantly higher late in the disease compared with the normal phenotype littermates. The data imply that early changes in enkephalin (also shown for leucine enkephalin in the spinal cord and brainstem) may be important to the etiology of the Wobbler disorder. Like the late increase of substance P, this may reflect a yet-to-be described response to parent cell degeneration in the raphe nuclei. TRH remained unchanged in Wobbler cerebellum and corpus striatum, wherein the other peptides studied herein also maintained similar concentrations to the normal phenotype littermates. |
Persistent Identifier | http://hdl.handle.net/10722/171572 |
ISSN | 2023 Impact Factor: 2.7 2023 SCImago Journal Rankings: 0.832 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yung, KKL | en_US |
dc.contributor.author | Tang, F | en_US |
dc.contributor.author | VaccaGalloway, LL | en_US |
dc.date.accessioned | 2012-10-30T06:15:44Z | - |
dc.date.available | 2012-10-30T06:15:44Z | - |
dc.date.issued | 1992 | en_US |
dc.identifier.citation | Brain Research, 1992, v. 599 n. 1, p. 175-180 | en_US |
dc.identifier.issn | 0006-8993 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/171572 | - |
dc.description.abstract | The Wobbler mouse possesses an inherited motoneuron disease, which expresses itself primarily at cervical spinal levels and in cranial motor nuclei. Cell degeneration is sporatic and negligible in other motor regions of the brain (e.g., cerebellum, corpus striatum). However, enkephalin concentrations are consistently lower in the Wobbler cerebellum throughout the motoneuron disease, whereas substance P concentrations are significantly higher late in the disease compared with the normal phenotype littermates. The data imply that early changes in enkephalin (also shown for leucine enkephalin in the spinal cord and brainstem) may be important to the etiology of the Wobbler disorder. Like the late increase of substance P, this may reflect a yet-to-be described response to parent cell degeneration in the raphe nuclei. TRH remained unchanged in Wobbler cerebellum and corpus striatum, wherein the other peptides studied herein also maintained similar concentrations to the normal phenotype littermates. | en_US |
dc.language | eng | en_US |
dc.publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/brainres | en_US |
dc.relation.ispartof | Brain Research | en_US |
dc.subject | Cerebellum | - |
dc.subject | Corpus striatum | - |
dc.subject | Leucine enkephalin | - |
dc.subject | Methionine enkephalin | - |
dc.subject | Motoneuron disease | - |
dc.subject | Radioimmunoassay | - |
dc.subject | Substance P | - |
dc.subject | Thyrotropin-releasing hormone | - |
dc.subject | Wobbler mouse | - |
dc.subject.mesh | Aging - Physiology | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Cerebellum - Metabolism | en_US |
dc.subject.mesh | Corpus Striatum - Metabolism | en_US |
dc.subject.mesh | Enkephalin, Leucine - Metabolism | en_US |
dc.subject.mesh | Enkephalin, Methionine - Metabolism | en_US |
dc.subject.mesh | Enkephalins - Metabolism | en_US |
dc.subject.mesh | Mice | en_US |
dc.subject.mesh | Mice, Neurologic Mutants | en_US |
dc.subject.mesh | Motor Neuron Disease - Genetics - Metabolism - Physiopathology | en_US |
dc.subject.mesh | Substance P - Metabolism | en_US |
dc.subject.mesh | Thyrotropin-Releasing Hormone - Metabolism | en_US |
dc.title | Decrease of enkephalins in cerebellum during Wobbler mouse motoneuron disease | en_US |
dc.type | Article | en_US |
dc.identifier.email | Tang, F:ftang@hkucc.hku.hk | en_US |
dc.identifier.authority | Tang, F=rp00327 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/0006-8993(92)90869-B | en_US |
dc.identifier.pmid | 1283561 | - |
dc.identifier.scopus | eid_2-s2.0-0027049414 | en_US |
dc.identifier.volume | 599 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.spage | 175 | en_US |
dc.identifier.epage | 180 | en_US |
dc.identifier.isi | WOS:A1992KF96900026 | - |
dc.publisher.place | Netherlands | en_US |
dc.identifier.scopusauthorid | Yung, KKL=36840201600 | en_US |
dc.identifier.scopusauthorid | Tang, F=7201979770 | en_US |
dc.identifier.scopusauthorid | VaccaGalloway, LL=6602468305 | en_US |
dc.identifier.issnl | 0006-8993 | - |